Clobazam, as an adjunct therapy, improved symptoms and quality of life for children with Lennox-Gastaut syndrome.
This gap in treatment may be increasing the risk for medical events and hospitalization in these patients.
The Food and Drug Administration (FDA) has approved Nayzilam (midazolam) nasal spray for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity.
Refined guidelines may benefit the treatment and monitoring of epilepsy in pregnant women.
Different cognitive phenotypes based on neuropsychological measures of language and memory are associated with distinct patterns of white matter abnormalities in patients with temporal lobe epilepsy.
Investigators analyzed clinical and neuroimaging factors related to cognitive outcome after epilepsy surgery in childhood.
Findings suggest VNS to be effective in the treatment of epilepsy and comorbid depression.
Recent data suggest that FS may contribute to sudden unexplained death in childhood.
Investigators sought to determine the relationship between electrographic effects of responsive neurostimulation, established in electrocorticographic recordings from the device, and patient outcomes.
Investigators evaluated the safety and tolerability of oral Vitamin D3 5000 IU/d in patients with drug-resistant epilepsy.